FOUNTAIN VALLEY, CALIFORNIA -- (MARKET WIRE) -- May 23, 2007 -- Sutura, Inc. (“Sutura”) (OTCBB: SUTU), an innovative developer of minimally invasive vascular suturing devices, announced today it is has received notice of issuance of a critical patent to add to its intellectual property portfolio. This strategic patent, which was issued to Sutura for device and method of suturing, relates to several key features of the core SuperStitch and HeartStitch technology.
